Badur Selim, Ozudogru Onur, Khalaf Mansour, Ozturk Serdar, Albreiki Sarah, Al Awaidy Salah, Guzman-Holst Adriana
GSK, Istanbul, Turkey.
GSK, Dubai, United Arab Emirates.
Infect Dis Ther. 2023 Jan;12(1):81-93. doi: 10.1007/s40121-022-00715-8. Epub 2022 Dec 3.
The reactivation of varicella zoster virus (VZV) in previously infected individuals can cause herpes zoster (HZ), which is characterized by a localized, painful dermatomal rash. While there is a global trend of increasing HZ cases, there is a lack of research examining the epidemiology of HZ within the Gulf Cooperation Council (GCC) countries. Therefore, we aimed to critically appraise evidence on VZV and HZ epidemiology in the GCC countries and identify gaps in the current literature.
A literature review was conducted via a comprehensive appraisal of the literature. PubMed and local-language journals were searched to identify articles related to HZ and VZV published up until 31 January 2022, with a sole focus on the GCC countries. Included studies reported on surveillance data, seroepidemiology, and patient outcomes for HZ and VZV, and comprised primary data reports, case series, case reports, narrative and systematic literature reviews, studies reporting HZ incidence or prevalence, and Ministry of Health reports.
Thirteen studies were found that reported on VZV seroprevalence in Saudi Arabia, the United Arab Emirates (UAE), and Qatar, ranging from 15.0% to 92.2%, while no data were identified for Bahrain, Kuwait, or Oman. There was very limited country-wide information on the incidence of HZ in GCC countries, and three identified studies reported HZ prevalence as seen in a single clinic, ranging from 0.62% to 2.3%. A single study from Saudi Arabia and government surveillance data reported on the impact of VZV vaccination on VZV infection, though there was no evidence on the impact of VZV vaccination on HZ.
There is a clear gap in the literature regarding the incidence of HZ infection, and the impacts of HZ and VZV vaccinations in the GCC countries. Further research into the epidemiology of HZ is necessary to inform the implementation of vaccination programs in the GCC countries.
水痘带状疱疹病毒(VZV)在既往感染者体内重新激活可引发带状疱疹(HZ),其特征为局部疼痛性皮节皮疹。虽然全球范围内HZ病例呈增加趋势,但缺乏对海湾合作委员会(GCC)国家HZ流行病学的研究。因此,我们旨在严格评估GCC国家VZV和HZ流行病学的证据,并找出当前文献中的空白。
通过对文献进行全面评估开展文献综述。检索了PubMed和当地语言期刊,以识别截至2022年1月31日发表的与HZ和VZV相关的文章,重点仅关注GCC国家。纳入的研究报告了HZ和VZV的监测数据、血清流行病学及患者结局,包括原始数据报告、病例系列、病例报告、叙述性和系统性文献综述、报告HZ发病率或患病率的研究以及卫生部报告。
发现有13项研究报告了沙特阿拉伯、阿拉伯联合酋长国(阿联酋)和卡塔尔的VZV血清阳性率,范围为15.0%至92.2%,而未找到巴林、科威特或阿曼的数据。关于GCC国家HZ发病率的全国性信息非常有限,三项已识别的研究报告了单个诊所的HZ患病率,范围为0.62%至2.3%。沙特阿拉伯的一项研究和政府监测数据报告了VZV疫苗接种对VZV感染的影响,不过没有证据表明VZV疫苗接种对HZ有影响。
关于GCC国家HZ感染发病率以及HZ和VZV疫苗接种的影响,文献中存在明显空白。有必要进一步研究HZ流行病学,为GCC国家疫苗接种计划的实施提供依据。